Three Autism-Linked Genes Converge on Tweaks to Cells’ Timing

The genes are involved in pacing the development of inhibitory and excitatory neurons. An imbalance in these two types of signaling is thought to play a role in autism.

Written byAngie Voyles Askham and Spectrum
| 3 min read
Microscopy image showing patches of magenta and green
Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Mutations in three genes strongly associated with autism shift the pace at which certain inhibitory and excitatory neurons develop, according to a study published today in Nature. The findings reveal a novel point of convergence by which the mutations affect brain growth and activity, the researchers say.

“There is a problem of timing, basically,” says lead researcher Paola Arlotta, professor of stem cell and regenerative biology at Harvard University. That timing issue, she says, “may result later in imbalances in the way the circuit is wired and works.” An imbalance between excitatory and inhibitory signaling in the brain is thought to contribute to autism.

The three genes—ARID1B, CHD8 and SUV420H1 (also known as KMT5B)—are all involved in regulating chromatin, the complex of proteins and coiled DNA that makes up chromosomes. In addition to having an increased likelihood of autism, people who carry a mutation in one of these genes also ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies